Neuromuscular Disorders
Volume 19, Issue 3 , Pages 223-228 , March 2009

Immune-mediated rippling muscle disease with myasthenia gravis: A report of seven patients with long-term follow-up in two

  • Benedikt Schoser

      Affiliations

    • Department of Neurology, Friedrich Baur Institute, University of Munich, Ziemssenstr. 1a, D-80336 Munich, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 89 51607403; fax: +49 89 51607402.
    • ,
  • Saiju Jacob

      Affiliations

    • Department of Neuroimmunology, Oxford, UK
    • ,
  • David Hilton-Jones

      Affiliations

    • Department of Neurology, Oxford, UK
    • ,
  • Wolfgang Müller-Felber

      Affiliations

    • Haunersche Kinderklinik. University of Munich, Munich, Germany
    • ,
  • Christian Kubisch

      Affiliations

    • Institute of Human Genetics and Institute for Genetics, Cologne, Germany
    • ,
  • Detlef Claus

      Affiliations

    • Department of Neurology, Darmstadt, Germany
    • ,
  • Hans H. Goebel

      Affiliations

    • Department of Neuropathology, University of Mainz, Germany
    • ,
  • Giuseppe Vita

      Affiliations

    • Departments of Neuroscience, Psychiatry and Anesthesiology, University of Messina, Messina, Italy
    • ,
  • Angela Vincent

      Affiliations

    • Department of Neuroimmunology, Oxford, UK
    • ,
  • Antonio Toscano

      Affiliations

    • Departments of Neuroscience, Psychiatry and Anesthesiology, University of Messina, Messina, Italy
    • ,
  • Peter Van den Bergh

      Affiliations

    • Centre de Référence Neuromusculaire, Cliniques universitaires St-Luc, Université catholique de Louvain, Brussels, Belgium

Received 6 September 2008 ,Revised 30 December 2008 ,Accepted 6 January 2009.

References 

  1. Torbergsen T. A family with dominant hereditary myotonia, muscular hypertrophy, and increased muscular irritability, distinct from myotonia congenita Thomsen. Acta Neurol Scand. 1975;51(3):225–232
  2. Betz RC, Schoser BG, Kasper D, Ricker K, Ramirez A, Stein V, et al. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet. 2001;28(3):218–219
  3. Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology. 2004;62(4):538–543
  4. Vorgerd M, Bolz H, Patzold T, Kubisch C, Malin JP, Mortier W. Phenotypic variability in rippling muscle disease. Neurology. 1999;52(7):1453–1459
  5. Kubisch C, Schoser BG, von During M, Betz RC, Goebel HH, Zahn S, et al. Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease. Ann Neurol. 2003;53(4):512–520
  6. Vorgerd M, Ricker K, Ziemssen F, Kress W, Goebel HH, Nix WA, et al. A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation. Neurology. 2001;57(12):2273–2277
  7. Ricker K, Moxley RT, Rohkamm R. Rippling muscle disease. Arch Neurol. 1989;46(4):405–408
  8. Parton RG, Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol. 2007;8(3):185–194
  9. Kubisch C, Ketelsen UP, Goebel I, Omran H. Autosomal recessive rippling muscle disease with homozygous CAV3 mutations. Ann Neurol. 2005;57(2):303–304
  10. Ansevin CF, Agamanolis DP. Rippling muscles and myasthenia gravis with rippling muscles. Arch Neurol. 1996;53(2):197–199
  11. Ashok Muley S, Day JW. Autoimmune rippling muscle. Neurology. 2003;61(6):869–870
  12. Ansevin CF. Phenotypic variability in rippling muscle disease. Neurology. 2000;54(1):273–274
  13. Muller-Felber W, Ansevin CF, Ricker K, Muller-Jenssen A, Topfer M, Goebel HH, et al. Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis. Neuromuscul Disord. 1999;9(8):604–607
  14. Greenberg SA. Acquired rippling muscle disease with myasthenia gravis. Muscle Nerve. 2004;29(1):143–146
  15. Schulte-Mattler WJ, Kley RA, Rothenfusser-Korber E, Bohm S, Bruning T, Hackemann J, et al. Immune-mediated rippling muscle disease. Neurology. 2005;64(2):364–367
  16. Takagi A, Kojima S, Watanabe T, Ida M, Kawagoe S. Rippling muscle syndrome preceding malignant lymphoma. Int Med. 2002;41(2):147–150
  17. Watkins TC, Zelinka LM, Kesic M, Ansevin CF, Walker GR. Identification of skeletal muscle autoantigens by expression library screening using sera from autoimmune rippling muscle disease (ARMD) patients. J Cell Biochem. 2006;99(1):79–87
  18. Maselli RA, Richman DP, Wollmann RL. Inflammation at the neuromuscular junction in myasthenia gravis. Neurology. 1991;41(9):1497–1504
  19. Buckley C, Vincent A. Autoimmune channelopathies. Nat Clin Prac Neurol. 2005;1:22–33
  20. Fischer D, Schroers A, Blumcke I, Urbach H, Zerres K, Mortier W, et al. Consequences of a novel caveolin-3 mutation in a large German family. Ann Neurol. 2003;53(2):233–241
  21. Van den Bergh PY, Gerard JM, Elosegi JA, Manto MU, Kubisch C, Schoser BG. Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease. J Neurol Neurosurg Psychiatry. 2004;75(9):1349–1351
  22. Hernandez-Deviez DJ, Martin S, Laval SH, Lo HP, Cooper ST, North KN, et al. Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3. Hum Mol Genet. 2006;15(1):129–142
  23. Schubert W, Sotgia F, Cohen AW, Capozza F, Bonuccelli G, Bruno C, et al. Caveolin-1(-/-)- and caveolin-2(-/-)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation. Am J Pathol. 2007;170(1):316–333
  24. Walker GR, Watkins T, Ansevin CF. Identification of autoantibodies associated with rippling muscles and myasthenia gravis that recognize skeletal muscle proteins: Possible relationship of antigens and stretch-activated ion channels. Biochem Biophy Res Commun. 1999;264:430–435
  25. Buckley C, Newsom-Davis J, Willcox N, Vincent A. Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?. Neurology. 2001;57(9):1579–1582
  26. Parker S, Peterkin HS, Baylis HA. Muscular dystrophy associated mutations in caveolin-1 induce neurotransmission and locomotion defects in Caenorhabditis elegans. Invert Neurosci. 2007;7(3):157–164
  27. Carlson BM, Carlson JA, Dedkov EI, McLennan IS. Concentration of caveolin-3 at the neuromuscular junction in young and old rat skeletal muscle fibers. J Histochem Cytochem. 2003;51(9):1113–1118

PII: S0960-8966(09)00004-2

doi: 10.1016/j.nmd.2009.01.002

Neuromuscular Disorders
Volume 19, Issue 3 , Pages 223-228 , March 2009

Article Tools

* Image Usage & Resolution